Walid Rasheed

1.4k total citations
49 papers, 608 citations indexed

About

Walid Rasheed is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Walid Rasheed has authored 49 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 13 papers in Public Health, Environmental and Occupational Health and 12 papers in Oncology. Recurrent topics in Walid Rasheed's work include Hematopoietic Stem Cell Transplantation (15 papers), Acute Myeloid Leukemia Research (12 papers) and Acute Lymphoblastic Leukemia research (10 papers). Walid Rasheed is often cited by papers focused on Hematopoietic Stem Cell Transplantation (15 papers), Acute Myeloid Leukemia Research (12 papers) and Acute Lymphoblastic Leukemia research (10 papers). Walid Rasheed collaborates with scholars based in Saudi Arabia, United States and Egypt. Walid Rasheed's co-authors include Ricky W. Johnstone, H. Miles Prince, Mark Bishton, Mahmoud Aljurf, Fahad Alsharif, Amr Hanbali, Riad El Fakih, Naeem Chaudhri, Yousef M. Hawsawi and Said Mohamed and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Walid Rasheed

38 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Walid Rasheed Saudi Arabia 13 359 202 163 69 63 49 608
Toshiya Yokozawa Japan 8 281 0.8× 222 1.1× 100 0.6× 107 1.6× 108 1.7× 17 528
Marie Sébert France 13 281 0.8× 313 1.5× 123 0.8× 116 1.7× 62 1.0× 47 593
Xielan Zhao China 14 351 1.0× 244 1.2× 116 0.7× 106 1.5× 29 0.5× 49 611
Daniel H. Wiseman United Kingdom 15 529 1.5× 337 1.7× 96 0.6× 104 1.5× 60 1.0× 46 854
Ivan Pašić Canada 12 164 0.5× 238 1.2× 121 0.7× 47 0.7× 85 1.3× 80 514
Karsten Stahnke Germany 15 327 0.9× 197 1.0× 150 0.9× 76 1.1× 191 3.0× 23 635
V Ruppert Germany 10 308 0.9× 205 1.0× 205 1.3× 48 0.7× 176 2.8× 13 552
Agata Pastorczak Poland 13 217 0.6× 136 0.7× 96 0.6× 56 0.8× 210 3.3× 57 510
Anna Grazia Recchia Italy 16 265 0.7× 302 1.5× 166 1.0× 151 2.2× 154 2.4× 38 653

Countries citing papers authored by Walid Rasheed

Since Specialization
Citations

This map shows the geographic impact of Walid Rasheed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walid Rasheed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walid Rasheed more than expected).

Fields of papers citing papers by Walid Rasheed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walid Rasheed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walid Rasheed. The network helps show where Walid Rasheed may publish in the future.

Co-authorship network of co-authors of Walid Rasheed

This figure shows the co-authorship network connecting the top 25 collaborators of Walid Rasheed. A scholar is included among the top collaborators of Walid Rasheed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walid Rasheed. Walid Rasheed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mobeireek, Abdullah F., Walid Rasheed, Tusneem Elhassan, et al.. (2025). Role of Fiberoptic Bronchoscopy in Decision‐Making in the Management of Post‐Hematopoietic Stem Cell Transplant Patients Presenting with Pulmonary Infiltrates: A Retrospective Cohort Study. Transplant Infectious Disease. 27(2). e14441–e14441.
2.
Rasheed, Walid, et al.. (2025). Programmed death inhibitors in CNS B-cell lymphoma: A literature review. Blood Reviews. 74. 101321–101321.
3.
Alamer, Abdullah, et al.. (2024). Minimal residual disease testing for classical Hodgkin lymphoma: A comprehensive review. Critical Reviews in Oncology/Hematology. 204. 104503–104503. 3 indexed citations
4.
Al‐Jefri, Abdullah, Ahmad S. Alotaibi, Mansour Alfayez, et al.. (2024). First Description of New Variant of Germline ERCC6L2 Mutations Causing Bone Marrow Failure, a Single Center Report of 11 Cases in 7 Families. Blood. 144(Supplement 1). 5706–5706.
5.
Chaudhri, Naeem, Ayman Saad, Abdullah Alamer, et al.. (2023). The Outcome of Tisagenlecleucel (Tisa-Cel) Vs Axicabtagene Ciloleucel (Axi-Cel) CD-19 CAR-T Cell Therapy in Relapsed/Refractory NHL, Real World Data, Single Institution Experience. Blood. 142(Supplement 1). 6936–6936. 1 indexed citations
6.
Muhsen, Ibrahim N., et al.. (2023). Parasitic infections in hematopoietic stem cell transplant recipients. Transplant Infectious Disease. 25(S1). e14160–e14160.
7.
Fakih, Riad El, Shahrukh K. Hashmi, Yasser Khafaga, et al.. (2021). Outcomes of autologous stem cell transplantation for multiple myeloma in Saudi Arabia. Annals of Saudi Medicine. 41(4). 198–205. 7 indexed citations
8.
Bakshi, Nasir, Walid Rasheed, Feras Alfraih, et al.. (2020). Evaluation of Eltrombopag in Thrombocytopenia Post Hematopoietic Cell Transplantation. Hematology/Oncology and Stem Cell Therapy. 15(1). 7–13. 14 indexed citations
9.
Alahmari, Ali, Mahmoud Aljurf, Amal Al-Seraihy, et al.. (2020). Hematopoietic stem cell transplantation for patients with sickle cell disease in the Eastern Mediterranean. Hematology/Oncology and Stem Cell Therapy. 13(2). 106–110. 1 indexed citations
10.
Alfraih, Feras, Mahmoud Aljurf, Hind Alhumaidan, et al.. (2020). High-resolution HLA allele and haplotype frequencies of the Saudi Arabian population based on 45,457 individuals and corresponding stem cell donor matching probabilities. Human Immunology. 82(2). 97–102. 11 indexed citations
11.
Harif, Mhamed, Daniel Weisdorf, Nicolás Novitzky, et al.. (2019). Special report. Hematology/Oncology and Stem Cell Therapy. 13(4). 202–207. 16 indexed citations
12.
Fakih, Riad El, et al.. (2018). Targeting FLT3 Mutations in Acute Myeloid Leukemia. Cells. 7(1). 4–4. 36 indexed citations
13.
Fakih, Riad El, et al.. (2018). Azacitidine Use for Myeloid Neoplasms. Clinical Lymphoma Myeloma & Leukemia. 18(4). e147–e155. 6 indexed citations
14.
Brockmann, Jens, Dieter C. Bröering, Walid Rasheed, et al.. (2018). Solid organ transplantation following allogeneic haematopoietic cell transplantation: experience from a referral organ transplantation center and systematic review of literature. Bone Marrow Transplantation. 54(2). 190–203. 14 indexed citations
15.
Hashmi, Shahrukh K., Alok Srivastava, Walid Rasheed, et al.. (2017). Cost and quality issues in establishing hematopoietic cell transplant program in developing countries. Hematology/Oncology and Stem Cell Therapy. 10(4). 167–172. 16 indexed citations
16.
Rasheed, Walid, et al.. (2015). Plasma cell leukemia mimicking hairy cell leukemia. Hematology/Oncology and Stem Cell Therapy. 8(2). 91–92. 3 indexed citations
17.
Ahmed, Syed Osman, Fahad Alsharif, Said Mohamed, et al.. (2014). Leukemia during pregnancy. Hematology/Oncology and Stem Cell Therapy. 7(2). 63–68. 24 indexed citations
18.
Brahimi, Mohamed, et al.. (2012). A simplified method for autologous stem cell transplantation in multiple myeloma. Hematology/Oncology and Stem Cell Therapy. 5(1). 49–53. 9 indexed citations
19.
Lehé, Cynthia, Anne M. Dickinson, Walid Rasheed, et al.. (2010). Identification of a novel peptide derived from the M-phase phosphoprotein 11 (MPP11) leukemic antigen recognized by human CD8+ cytotoxic T lymphocytes. Hematology/Oncology and Stem Cell Therapy. 3(1). 24–33. 7 indexed citations
20.
Chaudhri, Naeem, Said Mohamed, Walid Rasheed, et al.. (2010). High efficacy and low toxicity of short-course oral valganciclovir as pre-emptive therapy for hematopoietic stem cell transplant cytomegalovirus infection. Hematology/Oncology and Stem Cell Therapy. 3(3). 116–120. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026